Board of Directors

Jennifer Good
Director


Ms. Good, a director of the Company since September 2017, is the co-founder, President, and Chief Executive Officer at Trevi Therapeutics, a late-stage clinical development company. Prior to founding Trevi, she served as President and Chief Executive Officer and as Chief Financial Officer at Penwest Pharmaceuticals, where she successfully led the transition of Penwest Pharmaceuticals from a development stage company to a profitable commercial stage company generating annual revenues in excess of $50 million and negotiating the sale of the Company to its major partner.

Ms. Good received a Bachelor of Business Administration degree with a Concentration in Accounting from Pacific Lutheran University in 1987 and is a Certified Public Accountant licensed by the State of Washington, although her license is currently inactive. Ms. Good is a board member of the Friedreich's Ataxia Research Alliance (FARA), which is a patient advocacy group advancing treatments for the cure of Friedreich's Ataxia.